Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lola Alonso-Guirado"'
Autor:
Elena Requena, Lola Alonso-Guirado, Javier Veloso, María Villarino, Paloma Melgarejo, Eduardo Antonio Espeso, Inmaculada Larena
Publikováno v:
Frontiers in Microbiology, Vol 13 (2023)
Penicillium rubens strain 212 (PO212) is a filamentous fungus belonging to the division Ascomycete. PO212 acts as an effective biocontrol agent against several pathogens in a variety of horticultural crops including Fusarium oxysporum f.sp. lycopersi
Externí odkaz:
https://doaj.org/article/a7c2cc146b184307888132077bb91eef
Autor:
Francisco Jurado-Rueda, Lola Alonso-Guirado, Tomin E Perea-Cham-blee, Oliver T Elliott, Ioan Filip, Raúl Rabadán, Núria Malats
Publikováno v:
Bioinformatics Advances. 3
MotivationHere, we performed a benchmarking analysis of five tools for microbe sequence detection using transcriptomics data (Kraken2, MetaPhlAn2, PathSeq, DRAC and Pandora). We built a synthetic database mimicking real-world structure with tuned con
Autor:
Patricia Sánchez-Jiménez, Marcos Elizalde-Horcada, Ancor Sanz-García, Inmaculada Granero-Cremades, María De Toledo, Paloma Pulido, Marta Navas, Ana Beatriz Gago-Veiga, Lola Alonso-Guirado, María Concepción Alonso-Cerezo, Desirée Nava-Cedeño, Francisco Abad-Santos, Cristina Virginia Torres-Díaz, María C. Ovejero-Benito
Publikováno v:
Molecular neurobiology.
Epigenetic changes such as DNA methylation were observed in drug-resistant temporal lobe epilepsy (DR-TLE), a disease that affects 25-30% of epilepsy patients. The main objective is to simultaneously describe DNA methylation patterns associated with
Autor:
Patricia Sánchez Jiménez, Marcos Elizalde-Horcada, Ancor Sanz-García, Inmaculada Granero-Cremades, María De Toledo, Paloma Pulido, Marta Navas, Ana Beatriz Gago-Veiga, Lola Alonso-Guirado, María Concepción Alonso-Cerezo, Desirée Nava-Cedeño, Francisco Abad-Santos, Cristina Virginia Torres-Díaz, María Carmen Ovejero-Benito
Epilepsy is a disabling neurological disease that affects 2% of the population. Drug-resistant epilepsy (DRE) affects 25-30% of epilepsy patients. Understanding its underlying mechanisms is key to adequately manage this condition. To analyze the main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0272211216f0b3f8f16e4045bc620636
https://doi.org/10.1101/2022.03.14.22271975
https://doi.org/10.1101/2022.03.14.22271975